Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data

od Davies, Michael J., Merton, Katherine, Vijapurkar, Ujjwala, Yee, Jacqueline, Qiu, Rong
Izdano u Cardiovasc Diabetol (2017)

Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin

od Leiter, Lawrence A., Langslet, Gisle, Vijapurkar, Ujjwala, Davies, Michael J., Canovatchel, William
Izdano u Diabetes Ther (2016)

A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures

od Patel, Charmi A., Bailey, Robert A., Vijapurkar, Ujjwala, Meininger, Gary, Blonde, Lawrence
Izdano u BMC Health Serv Res (2016)

Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc ana...

od Pfeifer, Michael, Townsend, Raymond R., Davies, Michael J., Vijapurkar, Ujjwala, Ren, Jimmy
Izdano u Cardiovasc Diabetol (2017)

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

od Davies, Michael J, Merton, Katherine W, Vijapurkar, Ujjwala, Balis, Dainius A, Desai, Mehul
Izdano u Diabetes Metab Syndr Obes (2017)

Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials

od Gilbert, Richard E., Mende, Christian, Vijapurkar, Ujjwala, Sha, Sue, Davies, Michael J., Desai, Mehul
Izdano u Diabetes Ther (2017)

Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis

od Sinclair, Alan J., Bode, Bruce, Harris, Stewart, Vijapurkar, Ujjwala, Shaw, Wayne, Desai, Mehul, Meininger, Gary
Izdano u J Am Geriatr Soc (2016)

Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

od Weir, Matthew R., Januszewicz, Andrzej, Gilbert, Richard E., Vijapurkar, Ujjwala, Kline, Irina, Fung, Albert, Meininger, Gary
Izdano u J Clin Hypertens (Greenwich) (2014)

Efficacy and Safety of Canagliflozin in Type 2 Diabetes Patients of Different Ethnicity

od Davidson, Jaime A., Aguilar, Richard, Lavalle González, Fernando J., Trujillo, Angelina, Alba, Maria, Vijapurkar, Ujjwala, Meininger, Gary
Izdano u Ethn Dis (2016)

Response to Stavropoulos

od Townsend, Raymond R., Machin, Israel, Ren, Jimmy, Trujillo, Angelina, Kawaguchi, Masato, Vijapurkar, Ujjwala, Damaraju, C. V., Pfeifer, Michael
Izdano u J Clin Hypertens (Greenwich) (2016)

Reductions in Mean 24‐Hour Ambulatory Blood Pressure After 6‐Week Treatment With Canagliflozin in Patients With Type 2 Diabetes Mellitus and Hypertension

od Townsend, Raymond R., Machin, Israel, Ren, Jimmy, Trujillo, Angelina, Kawaguchi, Masato, Vijapurkar, Ujjwala, Damaraju, Chandrasekharrao V., Pfeifer, Michael
Izdano u J Clin Hypertens (Greenwich) (2015)

Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies

od Sinclair, Alan, Bode, Bruce, Harris, Stewart, Vijapurkar, Ujjwala, Mayer, Cristiana, Fung, Albert, Shaw, Wayne, Usiskin, Keith, Desai, Mehul, Meininger, Gary
Izdano 2014

Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial

od Khorana, Alok A., McNamara, Mairéad G., Kakkar, Ajay K., Streiff, Michael B., Riess, Hanno, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Soff, Gerald A.
Izdano u TH Open (2020)

Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study

od Vadhan‐Raj, Saroj, McNamara, Mairéad G., Venerito, Marino, Riess, Hanno, O'Reilly, Eileen M., Overman, Michael J., Zhou, Xiao, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Khorana, Alok A.
Izdano u Cancer Med (2020)